Positions
- Assistant Professor
-
Medicine
Endocrinology, Diabetes and Metabolism
ÌÇÐÄÊÓÆµ of Medicine
Houston, TX, US
Addresses
- Dan L Duncan Comprehensive Cancer Center (Office)
-
O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
1919 Old Spanish Trail
Houston, TX, 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4597
sara.bedrose@bcm.edu
- 7200 Cambridge Street (Clinic)
-
Suite 8B
Houston, TX, 77030
United States
Phone: (713) 798-4736
- Baylor St Luke's medical center (Hospital)
-
6720 Bertner Ave
Houston, TX, 77030
United States
Education
- MD from Faculty of Medicine, Ain Shams Univeristy
- 12/2011 - Cairo, Egypt
- MS from RUSH University
- 05/2018 - Chicago, Illinois, United States
- Residency at John H Stroger Jr Hospital of Cook County
- 06/2018 - Chicago, Illinois, United States
- Clinical Fellowship at ÌÇÐÄÊÓÆµ of Medicine
- 06/2020 - Houston, Texas, United States
- Research Fellowship at MD Anderson Cancer Center
- Houston, Texas, United States
Certifications
- American board of Internal Medicine
- #388158
- ABIM
- Texas Medical License
- #R7663
- TMB
Honors & Awards
- Glenn Gunnigham award
- Award for Clinical Excellence
- BCM (06/2020)
Professional Statement
" Endocrinology is the art of using our understanding of the normal physiology to help treat any glandular pathology. Throughout the years, I realized how much I learn more every day of the human body that does not stop teaching us how smart and sophisticated it is ".
Dr. Bedrose graduated from Faculty of Medicine, Ain Shams University in Cairo, Egypt with grade excellent with honors. She completed her Internal Medicine residency at John H. Stroger Jr Hospital of Cook County in Chicago, IL. She earned a Masters of Sciences degree in Clinical Research from RUSH university in Chicago, IL. She then completed her fellowship program in Endocrinology, Diabetes and Metabolism at Baylor college of Medicine and was nominated by her colleagues for the Glenn Cunningham award upon graduation. She holds certification from the American Board of Internal Medicine and is board eligible for the ABIM Endocrinology, Diabetes and Metabolism.
Dr. Bedrose is compassionate about helping patients with disorders of the adrenal gland including adrenal nodules, incidentaloma, indeterminate adrenal nodules, Adrenal cancer, Congenital adrenal hyperplasia in adults . She is also compassionate about helping patients with endocrine neoplasia disorders including Immunotherapy related endocrine side effects. She also treats bone disorders as Osteoporosis, Osteomalacia as well as general endocrine diseases and diabetes.
Dr. Bedrose graduated from Faculty of Medicine, Ain Shams University in Cairo, Egypt with grade excellent with honors. She completed her Internal Medicine residency at John H. Stroger Jr Hospital of Cook County in Chicago, IL. She earned a Masters of Sciences degree in Clinical Research from RUSH university in Chicago, IL. She then completed her fellowship program in Endocrinology, Diabetes and Metabolism at Baylor college of Medicine and was nominated by her colleagues for the Glenn Cunningham award upon graduation. She holds certification from the American Board of Internal Medicine and is board eligible for the ABIM Endocrinology, Diabetes and Metabolism.
Dr. Bedrose is compassionate about helping patients with disorders of the adrenal gland including adrenal nodules, incidentaloma, indeterminate adrenal nodules, Adrenal cancer, Congenital adrenal hyperplasia in adults . She is also compassionate about helping patients with endocrine neoplasia disorders including Immunotherapy related endocrine side effects. She also treats bone disorders as Osteoporosis, Osteomalacia as well as general endocrine diseases and diabetes.
Selected Publications
-
Sara Bedrose, Kevin, Lina Altameemi L , Mohamed S Ali , Sameh Nassar , Naveen Garg , Marilyne Daher , Keith D Eaton, Jeffrey T. Yorio , Davey B Daniel , Matthew Campbell, Keith C Bible , Mabel Ryder , Ashish V Chintakuntlawar, Mouhammed Amir Habra. " " Jounral for Immunotherapy of Cancer. 2020 Jul ;
Pubmed PMID: . -
Bedrose S, Daher M, Altameemi L, Habra MA. " " Cancers, Volume 12; doi:10.3390/cancers12020508. 2020 Feb ; 12
Pubmed PMID: . -
Bedrose S, Altameemi L, Daher M, Tamsen G, Varghese J, Jimenez C, Campell M, Habra M. " SAT-175 Trial in Progress Interim report: Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma.. " Journal of the Endocrine Society doi:10.1210/jendso/bvaa 046.508. 2020 Apr ;
-
Bedrose S, Turin Moore C, Sang K, Lavis V, Thosani S.. " " Endocrine Practice- AACE Jan/Feb 2020, Vol.6, No 1, pp. e40-45. 2020 Jan ; 6
Pubmed PMID: .
Memberships
- ACP
- AACE
- Endocrine Society
- Egyptian Medical Syndicate
Languages
Arabic
to edit your profile